NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 82 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $33,000 | -45.9% | 35,400 | -22.9% | 0.00% | – |
Q4 2015 | $61,000 | -41.9% | 45,900 | 0.0% | 0.00% | – |
Q3 2015 | $105,000 | +41.9% | 45,900 | 0.0% | 0.00% | – |
Q2 2015 | $74,000 | +13.8% | 45,900 | +12.5% | 0.00% | – |
Q1 2015 | $65,000 | -36.9% | 40,800 | -25.4% | 0.00% | – |
Q4 2014 | $103,000 | +14.4% | 54,700 | -19.9% | 0.00% | – |
Q3 2014 | $90,000 | -10.9% | 68,300 | 0.0% | 0.00% | – |
Q2 2014 | $101,000 | -19.2% | 68,300 | +1.0% | 0.00% | – |
Q1 2014 | $125,000 | -32.8% | 67,596 | -24.6% | 0.00% | – |
Q4 2013 | $186,000 | -52.8% | 89,696 | -39.7% | 0.00% | – |
Q3 2013 | $394,000 | -7.9% | 148,696 | -7.2% | 0.00% | – |
Q2 2013 | $428,000 | – | 160,236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |